ILLUMINATE-A, a phase 3 study of lumasiran, an investigational RNAi therapeutic, in children and adults with primary hyperoxaluria type 1 (PH1)

被引：0

作者：

Garrelfs, Sander ^{[1
]}

Frishberg, Yaacov ^{[2
]}

Hulton, Sally ^{[3
]}

Koren, Michael ^{[4
]}

O'Riordan, William ^{[5
]}

Cochat, Pierre ^{[6
,7
,8
]}

Deschenes, Georges ^{[9
]}

Shasha-Lavsky, Hadas ^{[10
]}

Saland, Jeffrey ^{[11
]}

van't Hoff, William ^{[12
]}

Fuster, Daniel G. ^{[13
]}

Magen, Daniella ^{[14
]}

Moochhala, Shabbir ^{[15
]}

Schalk, Gesa ^{[16
]}

Simkova, Eva ^{[17
]}

Groothoff, Jaap ^{[1
]}

Sas, David ^{[18
]}

Meliambro, Kristin ^{[11
]}

Lu, Jiandong ^{[19
]}

Garg, Pushkal ^{[19
]}

Gansner, John ^{[19
]}

McGregor, Tracy ^{[19
]}

Lieske, John ^{[18
]}

机构：

[1] Amsterdam UMC, Dept Pediat Nephrol, Amsterdam, Netherlands

[2] Shaare Zedek Med Ctr, Div Pediat Nephrol, Jerusalem, Israel

[3] Birmingham Childrens Hosp, Dept Nephrol, Birmingham, W Midlands, England

[4] Jacksonville Ctr Clin Res, Jacksonville, FL USA

[5] EStudySite, San Diego, CA USA

[6] Hosp Civils Lyon, Lyon, France

[7] Univ Lyon, Ctr Rare Renal Dis, Lyon, France

[8] INSERM, Pediat Clin Invest Ctr, Lyon, France

[9] Hosp Robert Debre, Dept Pediat Nephrol, Paris, France

[10] Galilee Med Ctr, Nahariyya, Israel

[11] Icahn Sch Med, New York, NY USA

[12] Great Ormond St Hosp Sick Children, Dept Pediat Nephrol, London, England

[13] Univ Bern, Div Nephrol & Hypertens, Inselspital, Univ Hosp Bern, Bern, Switzerland

[14] Rambam Hlth Care Campus, Dept Pediat Nephrol, Haifa, Israel

[15] Royal Free Hosp, London, England

[16] Univ Bonn, Bonn, Germany

[17] Al Jalila Childrens Hosp, Dubai, U Arab Emirates

[18] Mayo Clin, Rochester, MN USA

[19] Alnylam Pharmaceut, Cambridge, MA USA

来源：

SWISS MEDICAL WEEKLY | 2020年

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OC 15

引用

页码：8S / 8S

页数：1

共 50 条

[41] Characteristics of a Brazilian cohort with primary hyperoxaluria type 1 (PH1), an admixed population with different ethnic origins
Vaisbich, Maria
Naghettini, Alessandra
Melo, Ana Paula
Molin, Christine Zomer Dal
Sylvestre, Lucimary C.
Requiao, Lucio M.
Da Rocha, Pedro Tulio
Sobral, Roberta M. L.
Michelon, Tatiana
Cerqueira, Tiago L.
Vitorino, Vanessa
Heilberg, Ita Pfeferman
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
[42] Primary Hyperoxaluria (PH): Type 1, 2, 3 or none?
Menetrey, Anika
Stahr, Nicolai
Rothlisberger, Benno
Neuhaus, Thomas
SWISS MEDICAL WEEKLY, 2018, 148 : 23S - 23S
[43] PRIMARY HYPEROXALURIA (PH): TYPE 1, 2, 3 OR NONE?
Menetrey, A.
Neuhaus, T.
Nikolai, S.
Rothlisberger, B.
SWISS MEDICAL WEEKLY, 2018, 148 : 65S - 65S
[44] Characteristics of a Brazilian cohort with primary hyperoxaluria type 1 (PH1), an admixed population with different ethnic origins
Vaisbich, Maria
Naghettini, Alessandra
Melo, Ana Paula
Dal Molin, Christine Zomer
Sylvestre, Lucimary C.
Requiao, Lucio M.
Da Rocha, Pedro Tulio
Sobral, Roberta M. L.
Michelon, Tatiana
Cerqueira, Tiago L.
Vitorino, Vanessa
Heilberg, Ita Pfeferman
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I449 - I450
[45] Optimization of Hydroxyacidoxidase 1(HAO1) Targeting ARCUS Nucleases for the Treatment of Primary Hyperoxaluria Type 1 (PH1)
Owens, Gary
Lewis, Whitney C.
Jordan-Steele, Matthew
Polak, Rachel
Lape, Janel
Smith, Jeff
Holt, Jason
Falls, Greg
Jantz, Derek
MOLECULAR THERAPY, 2022, 30 (04) : 116 - 116
[46] COMBINED KIDNEY-LIVER TRANSPLANTATION OR KIDNEY TRANSPLANTATION ALONE FOR PRIMARY HYPEROXALURIA TYPE 1 (PH1): A FRENCH MULTICENTRIC STUDY
Metzler, Philippe
Camus, Christophe
Rivalan, Joseph
Niaudet, Patrick
Samuel, Didier
Durrbach, Antoine
Bayle, Francois
Lang, Philippe
Merville, Pierre
Thervet, Eric
Bensman, Albert
Rostaing, Lionel
Deschenes, Georges
Boudjema, Karim
Compagnon, Philippe
LIVER TRANSPLANTATION, 2009, 15 (07) : S95 - S96
[47] Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1 : Results from a Phase III Clinical Trial
Saland, Jeffrey M.
Lieske, John C.
Groothoff, Jaap W.
Frishberg, Yaacov
Shasha-Lavsky, Hadas
Magen, Daniella
Moochhala, Shabbir H.
Simkova, Eva
Coenen, Martin
Hayes, Wesley
Hogan, Julien
Sellier-Leclerc, Anne-Laure
Willey, Richard
Gansner, John M.
Hulton, Sally -Anne
KIDNEY INTERNATIONAL REPORTS, 2024, 9 (07): : 2037 - 2046
[48] Market Research Studies Across Primary Hyperoxaluria (PH) Subtypes: PH1, PH2, and PH3
Dallosso, Claudia
Julien, Donald P.
Buckland, Guy
Hengst, Scott
Eckford, David
Okonis, Chris
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 815 - 815
[49] COMBINED HEPATIC AND RENAL-TRANSPLANTATION IN PRIMARY HYPEROXALURIA TYPE-1 (PH1) - LONG-TERM RESULTS
FAUCHALD, P
FLATMARK, A
JELLUM, E
SODAL, G
JORSTAD, S
TRANSPLANTATION PROCEEDINGS, 1994, 26 (03) : 1799 - 1800
[50] Primary Hyperoxaluria Type 1 (PH1) Presenting With End-Stage Kidney Disease and Cutaneous Manifestations in Adulthood: A Case Report
Poyah, Penelope
Bergman, Joel
Geldenhuys, Laurette
Wright, Glenda
Walsh, Noreen M.
Hull, Peter
Roche, Kristina
West, Michael L.
CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2021, 8

← 1 2 3 4 5 →